Alerislife Inc (ALR)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3200 +0.0100 (+0.76%) 03/17/23 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3200 unch (unch) -
for Fri, Mar 17th, 2023
Results
download Want to compare other data? Select FieldsSymbol | ALR | ATAI | DXR | ||
Company | Alerislife Inc | Atai Life Sciences N.V. | Daxor Corp | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 1.3100 | 1.4800 | 7.83 | ||
High | 1.3200 | 1.5400 | 7.83 | ||
Low | 1.3034 | 1.4100 | 7.83 | ||
Last | 1.3200 | 1.4600 | 7.83 | ||
Change | +0.0100 | -0.0700 | +0.06 | ||
% Change | +0.76% | -4.58% | +0.77% | ||
Volume | 111,900 | 2,230,300 | 200 | ||
20-Day Average Volume | 177,105 | 1,711,760 | 4,940 | ||
Previous Close | 1.3100 | 1.5300 | 7.77 | ||
Industry | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | Medical - Outpatient & Hm Care | ||
Has Options | No | Yes | No | ||
Technicals | |||||
20-Day Moving Average | 1.3165 | 1.3757 | 7.79 | ||
20-Day Raw Stochastic | 37.55% | 73.81% | 47.21% | ||
20-Day Relative Strength | 69.53% | 49.71% | 50.11% | ||
Weighted Alpha | -48.10 | -47.74 | -18.14 | ||
Today's Opinion | 88% Buy | 24% Sell | 56% Sell | ||
Previous Opinion | 72% Buy | 8% Sell | 72% Sell | ||
Last Month's Opinion | 24% Buy | 8% Buy | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.76% since 03/10/23 | -0.68% since 04/17/25 | +4.40% since 04/16/25 | ||
Low | 1.3000 on 03/16/23 | 1.4100 on 04/25/25 | 7.35 on 04/17/25 | ||
High | 1.3200 on 03/17/23 | 1.5600 on 04/23/25 | 7.98 on 04/21/25 | ||
1-Month | |||||
%Chg | -1.49% since 02/17/23 | -7.01% since 03/25/25 | -4.34% since 03/25/25 | ||
Low | 1.3000 on 03/16/23 | 1.1500 on 04/09/25 | 7.23 on 04/07/25 | ||
High | 1.3699 on 02/21/23 | 1.5800 on 03/27/25 | 8.65 on 03/26/25 | ||
3-Month | |||||
%Chg | +80.85% since 12/16/22 | -7.59% since 01/24/25 | -4.40% since 01/24/25 | ||
Low | 0.5487 on 12/30/22 | 1.1500 on 04/09/25 | 6.55 on 02/11/25 | ||
High | 1.3699 on 02/21/23 | 2.5650 on 02/12/25 | 8.99 on 01/28/25 | ||
6-Month | |||||
%Chg | +18.92% since 09/16/22 | +28.07% since 10/25/24 | -12.07% since 10/25/24 | ||
Low | 0.5487 on 12/30/22 | 1.0400 on 10/31/24 | 6.55 on 02/11/25 | ||
High | 1.5800 on 09/19/22 | 2.5650 on 02/12/25 | 10.00 on 12/02/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 43,044 | 261,731 | 36,954 | ||
Shares Outstanding, K | 32,609 | 199,795 | 4,837 | ||
Annual Sales | 942,390,000 | 310,000 | 1,450,000 | ||
Annual Net Income | -29,930,000 | -149,270,000 | -7,190,000 | ||
Last Quarter Sales | 182,660,000 | 40,000 | 342,584 | ||
Last Quarter Net Income | -8,510,000 | -26,290,000 | -1,491,188 | ||
60-Month Beta | 0.96 | 1.24 | -0.06 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.22 on 11/02/22 | -0.24 on 03/17/25 | N/A | ||
Latest Earnings Date | 03/22/23 | 05/21/25 | 03/06/25 | ||
Most Recent Dividend | N/A | N/A | 0.030 on 01/05/18 | ||
Next Ex-Dividends Date | N/A | 06/08/17 | 01/05/18 | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |